Public Release: 

Genetically altering female mice prevents diet-induced obesity, study shows

Deleting specific microRNA helped prevent weight gain in mice, despite diet

The Ohio State University Wexner Medical Center

COLUMBUS, Ohio - Researchers at The Ohio State University Wexner Medical Center seeking a way to combat the growing epidemic of obesity have found that deleting microRNA-155 in female mice prevents diet-induced obesity.

The findings are published online in the journal Scientific Reports.

"Obese individuals are susceptible to heart disease and metabolic syndrome, which is why it's important to find new ways to protect them from the effects of a high fat diet," said lead author Phillip G. Popovich, professor of neuroscience and director of The Center for Brain and Spinal Cord Repair at Ohio State's Neurological Institute.

In their study, researchers deleted a specific microRNA (miR) which is a small, non-coding RNA that influences and regulates gene transcription in cells and affects how they function. Researchers hypothesized that a specific miR -- miR-155 -- would be a good target because it may regulate several signaling pathways that are involved in the development and maintenance of obesity.

Researchers studied female wild-type mice and miR-155 knockout mice that were fed a control diet or a high-fat diet for 12 weeks. Surprisingly, despite eating a high-fat diet for 3 months, miR-155 knockout mice did not become obese. Compared to wild-type mice, weight gain in miR-155 knockout mice was reduced 56 percent with a 74 percent reduction in accumulation of fat. Experiments using male mice produced similar results.

The study also found that miR-155 deletion could enhance metabolic rate, an effect that could explain the reduced obesity in these mice. Compared to female wild-type mice, miR-155 knockout mice lost 78 percent more body weight after overnight fast, and miR-155 knockout mice increased energy expenditure (heat production) by 14 percent over wild-type mice.

"MicroRNAs target hundreds of mRNAs simultaneously, so they represent a promising class of molecules for improving outcomes of disease," said first author and former Ohio State researcher Andrew D. Gaudet, who is now at the University of Colorado Boulder. "Our study shows that manipulating miR-155 improves how cells respond to high fat intake. This suggests that altering microRNA expression is an attractive potential therapy for obesity."


Other Ohio State researchers involved in the study are Laura K. Fonken, Liubov V. Gushchina, Taryn G. Aubrecht, Santosh K. Maurya, Muthu Periasamy and Randy J. Nelson. This study was a collaborative effort across several laboratories linked by the Ohio State's Neuroscience Research Institute.

This work was supported by a Canadian Institutes of Health Research, Postdoctoral Fellowship, an American Heart Association Predoctoral Fellowship, National Institutes of Health Postdoctoral F32 AG048672-02, NIDCR grant T32 DE014320, NSF grant IOS 11-18792, the Ray W. Poppleton Endowment, International Foundation for Research in Paraplegia grant P129, and NIH-NINDS R21 NS081413. Behavioral tests were supported by NIH P30 NS045758.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.